HIV Antiviral Drugs - Search News

News

FDA Approves HIV Shot That’s 99.9% Effective

FDA approves first twice-yearly injection that prevents HIV infection

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday.Sold under the name Yeztugo,

Forbes on MSN · 3d

FDA Greenlights Twice-A-Year HIV Prevention Drug

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. The drug (which has the generic name lenacapavir) will become available in the U.S. following the approval, though it’s unclear who will initially have access to the drug.

TIME on MSN · 3d

FDA Approves a Twice-Yearly Shot to Prevent HIV

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Harvard Medical School2d

2025 Warren Alpert Prize Honors Scientists Whose Discoveries Culminated in Novel HIV Treatment

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

Managed Healthcare Executive3d

Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

MedPage Today on MSN3d

FDA Approves Twice-Yearly Shot for HIV Prevention

The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results